IRCT20111206008307N40RecruitingPhase 3
Evaluation Effect of Empagliflozin and Colchicine on Quality of life in Heart Failure with Reduced Ejection Fraction: A Randomized Clinical Trial
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 80 years (—)
- Sex
- All
Inclusion Criteria
- •Heart Failure with Reduced Ejection Fraction
- •Aged 18 to 80 years
- •Consented patients
Exclusion Criteria
- •Liver failure
- •Kidney failure
- •Systolic blood pressure less than 100 or more than 180 mm Hg
- •Diabetes mellitus
Investigators
Similar Trials
Completed
Phase 3
Effects of Colchicine and Empagliflozin in Myocardial DysfunctioHeart failureIRCT20111206008307N39Tabriz University of Medical Sciences96
Recruiting
Phase 3
Effect of Empagliflozin in PrediabetesCondition 1: Impaired fasting glucose. Condition 2: Impaired glucose tolerance.Impaired fasting glucoseImpaired glucose tolerance (oral)R73.01R73.02IRCT20220902055858N1Shahre-kord University of Medical Sciences90
Not yet recruiting
Phase 3
Comparison of therapeutic effect of Empagliflozin (Gloripa) and Sitagliptin (Ziptin) on type 2 Diabetic patientsIRCT20200810048355N1Vice Chancellor for Research, Islamic Aazad University, Najafabad branch128
Completed
Unknown
Evaluation of the effect of empagliflozin in combination with pioglitazone on fatty liver diseaseFatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20240208060939N1Artesh University of Medical Sciences80
Completed
Phase 3
Effect of Empagliflozin in prevention of kidney stone parametersIRCT20211203053261N2Hamedan University of Medical Sciences138